Nov. 21 (UPI) -- Healthcare giant Eli Lilly on Friday became the first global healthcare company to hit $1 trillion in value.
The Indiana-based company hit the $1 trillion market capitalization threshold for a brief period at roughly $1,061 a share during morning hour trading before it scaled back.
Warren Buffett's Berkshire Hathaway was the first known non-tech company to reach the trillion-dollar valuation mark.
The company is currently riding on the popularity of its Zepbound weightloss inject and Mounjaro, which is Eli's diabetes treatment.
Eli Lilly has long been a player in the pharmaceutical industry for more than 100 years, introducing such medication as Prozac in the early 1990s and the Humulin insulin drug.
